Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for KOMBINATION VON EINEM NALOXOL-PEG-KONJUGATE UND EINEM OPIOIDAGONIST
Details for 2015188944
Up to date per 11.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2015188944
Title / Product Name
KOMBINATION VON EINEM NALOXOL-PEG-KONJUGATE UND EINEM OPIOIDAGONIST
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2015188944
EP Publication Number
2992903
E-Number
1290241
Language
EN
PCT Number
-
Publication Date
09.03.2016 A
15.07.2020 B1
Registration Date
15.07.2020
AT Publication Date
15.08.2020
Application Date
29.09.2011
Registration Number
-
Priorities
30.09.2010
US
388501 P
IPC
A61K 47/60 20170101AFI20190903BHEP
Maximum Duration of Protection
29.09.2031
Owner
AstraZeneca AB
151 85 Södertälje
SE
Nektar Therapeutics
455 Mission Bay Boulevard Suite 100
San Francisco, CA 94158
US
Representative
No representatives present
Inventor
ASLUND, Bengt Leonard
AstraZeneca R&D Södertälje
151 85 Södertälje
SE
AURELL, Carl-Johan
AstraZeneca R&D Södertälje
151 85 Södertälje
SE
BOHLIN, Martin Hans
AstraZeneca R&D Södertälje
151 85 Södertälje
SE
SEBHATU, Tesfai
AstraZeneca R&D Södertälje
151 85 Södertälje
SE
YMEN, Bo Ingvar
AstraZeneca R&D Södertälje
151 85 Södertälje
SE
HEALY, Eric Thomas
Nektar Therapeutics 455 Mission Bay Boulevard Suite 100
San Francisco, CA 94158
US
JENSEN, David Richard
Nektar Therapeutics 455 Mission Bay Boulevard Suite 100
San Francisco, CA 94158
US
JONAITIS, David Thomas
SSCI A Division of APTUIT 3065 Kent Avenue
West Lafayette, IN 47906-1076
US
PARENT, Stephan
SSCI A Division of APTUIT 3065 Kent Avenue
West Lafayette, IN 47906-1076
US